A simple high-throughput approach identifies actionable drug sensitivities in patient-derived tumor organoids.

Communications Biology
Nhan PhanAlice Soragni

Abstract

Tumor organoids maintain cell-cell interactions, heterogeneity, microenvironment, and drug response of the sample they originate from. Thus, there is increasing interest in developing tumor organoid models for drug development and personalized medicine applications. Although organoids are in principle amenable to high-throughput screenings, progress has been hampered by technical constraints and extensive manipulations required by current methods. Here we introduce a miniaturized method that uses a simplified geometry by seeding cells around the rim of the wells (mini-rings). This allows high-throughput screenings in a format compatible with automation as shown using four patient-derived tumor organoids established from two ovarian and one peritoneal high-grade serous carcinomas and one carcinosarcoma of the ovary. Using our automated screening platform, we identified personalized responses by measuring viability, number, and size of organoids after exposure to 240 kinase inhibitors. Results are available within a week from surgery, a timeline compatible with therapeutic decision-making.

References

May 28, 2003·Biotechnology and Bioengineering·Jens M KelmLars K Nielsen
Apr 22, 2004·Gynecologic Oncology·J Tate ThigpenUNKNOWN Gynecologic Oncology Group
Aug 18, 2004·Trends in Molecular Medicine·Sylvia FongPierre-Yves Desprez
Mar 17, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·M S ManoA Awada
Feb 14, 2009·Nature Protocols·Juergen FriedrichLeoni A Kunz-Schughart
Mar 17, 2010·The Journal of Pathology·Ahmed Ashour AhmedJames D Brenton
Apr 19, 2011·Journal of Cell Communication and Signaling·Agata NygaMarilena Loizidou
Dec 14, 2011·Molecular Carcinogenesis·Lauren C KimlinVictoria M Virador
Feb 24, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B MarkmanJ Baselga
Oct 18, 2012·Drug Discovery Today·Susan Breslin, Lorraine O'Driscoll
May 1, 2013·Nature Reviews. Drug Discovery·Richard Simon, Sameek Roychowdhury
Jul 11, 2013·Gynecologic Oncology·Erin M GeorgeJason D Wright
Jan 6, 2015·Cell·Sylvia F BojDavid A Tuveson
Apr 17, 2015·Science Translational Medicine·Kandice Tanner, Michael M Gottesman
Jan 23, 2016·OncoTargets and Therapy·Cristian MassacesiSamit Hirawat
Feb 7, 2016·Cancer Discovery·Emile E Voest, Rene Bernards
Feb 13, 2016·The Lancet Oncology·Vinay PrasadMichael Brada
Feb 24, 2016·Frontiers in Bioengineering and Biotechnology·Moriah E KattPeter C Searson
Jun 21, 2016·Gynecologic Oncology·J Alejandro Rauh-HainMarcela G Del Carmen
Sep 16, 2016·Methods in Molecular Biology·Hayley E FranciesMathew J Garnett
Sep 30, 2016·The New England Journal of Medicine·Ian F Tannock, John A Hickman
Nov 20, 2016·Clinical and Translational Science·C A CummingsM R Lackner
Jan 18, 2017·Biotechnology Journal·Kathrin Halfter, Barbara Mayer
Mar 24, 2017·Cancer Discovery·Chantal PauliMark A Rubin
Apr 14, 2017·Cancer Investigation·Qi Zhou
Sep 9, 2017·Nature Medicine·Anthony Letai
Oct 11, 2017·Nature Genetics·Uri Ben-DavidTodd R Golub
May 25, 2018·Expert Opinion on Drug Discovery·Ecaterina Ileana DumbravaTimothy A Yap
Jun 21, 2018·Nature Communications·Loredana PucaHimisha Beltran
Sep 1, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B MarkmanJ Baselga

❮ Previous
Next ❯

Citations

Nov 7, 2019·International Journal of Molecular Sciences·Maxime VermeulenChristine Wyns
Jul 3, 2019·Nature Reviews. Cancer·Holly E Barker, Clare L Scott
Aug 29, 2020·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Tristan Frum, Jason R Spence
Sep 5, 2019·Pharmaceutical Research·Meghana RawalMansoor M Amiji
Sep 17, 2020·Annual Review of Vision Science·Claire M BellCynthia A Berlinicke
Nov 11, 2019·Journal of Ovarian Research·Sander DumontDirk Timmerman
Jun 5, 2020·Cell Death and Differentiation·Lama AlzamilMargherita Y Turco
Sep 16, 2020·Cancer Metastasis Reviews·Michael W LeeAnna Capasso
Jan 2, 2020·APL Bioengineering·Gregory H Underhill, Salman R Khetani
Jun 9, 2020·Frontiers in Cellular and Infection Microbiology·Ka-Yee Grace ChoiRobert E W Hancock
Aug 23, 2020·Cancers·Roberta LarangaEnrico Lucarelli
Oct 13, 2020·Advanced Science·Xingwu ZhouAli Khademhosseini
Sep 4, 2020·Journal of Fish Diseases·Mingzhu LiuPengfei Li
Oct 20, 2020·Expert Opinion on Investigational Drugs·Sreenivasa R ChandanaDaruka Mahadevan
Dec 15, 2020·Critical Reviews in Oncology/hematology·Maxim Le CompteMichiel de Maat
Jan 23, 2021·Journal of Translational Medicine·Lisa LiuWeiRen Huang
Oct 18, 2019·Seminars in Cancer Biology·Holly E Barker, Clare L Scott
Feb 11, 2021·In Vitro Cellular & Developmental Biology. Animal·Terry Riss, O Joseph Trask
Jan 6, 2021·International Journal of Molecular Sciences·Tanya SinghSanaz Memarzadeh
Jan 12, 2021·Frontiers in Genetics·Junkai XieChongli Yuan
Sep 16, 2020·Cancer Treatment Reviews·Anita SemertzidouMaria Kyrgiou
Feb 20, 2021·Nature Communications·Sofia KarkampounaMarianna Kruithof-de Julio
Apr 2, 2021·Journal of Experimental & Clinical Cancer Research : CR·Camilla NeroClaudio Sette
Apr 4, 2021·International Journal of Molecular Sciences·Colin RaeChiara Braconi
Dec 7, 2020·Trends in Biotechnology·Xiao Qin, Christopher J Tape
Apr 14, 2021·NPJ Precision Oncology·G Emerens WensinkJeanine M L Roodhart
Apr 30, 2021·Laboratory Investigation; a Journal of Technical Methods and Pathology·Yuka HirashitaKazunari Murakami
Apr 30, 2021·Acta Biomaterialia·Anna StejskalováBenjamin D Almquist
May 8, 2021·Frontiers in Cell and Developmental Biology·Ruben HeremansHugo Vankelecom
Jun 3, 2021·Cancers·Antonio BarbáchanoAlberto Muñoz

❮ Previous
Next ❯

Datasets Mentioned

BETA
AZD5438

Methods Mentioned

BETA
xenografts

Software Mentioned

Celigo cell
Prism 7
EpMotion
Celigo S Imaging Cell Cytometer
Celigo S
Prism

Related Concepts

Related Feeds

Carcinosarcoma

Carcinosarcoma is a malignant neoplasm that contains elements of carcinoma and sarcoma so extensively intermixed as to indicate neoplasia of epithelial and mesenchymal tissue. Discover the latest research on carcinosarcoma here.